We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $113B
1-Year Est. Return 38.87%
This Fund
S&P 500
This Quarter Est. Return
+3%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+524.93%
AUM
$96.6B
AUM Growth
-$813M
Cap. Flow
-$2.51B
Cap. Flow %
-2.6%
Top 10 Hldgs %
13.1%
Holding
822
New
68
Increased
222
Reduced
455
Closed
69

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$743M
2
GILD icon
Gilead Sciences
GILD
+$513M
3
LH icon
Labcorp
LH
+$508M
4
CI icon
Cigna
CI
+$348M
5
EPAM icon
EPAM Systems
EPAM
+$304M

Sector Composition

Rank Sector Weight
1 Financials 20.9%
2 Technology 15.16%
3 Industrials 14.83%
4 Healthcare 12.72%
5 Consumer Discretionary 10.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESI icon
326
Element Solutions
ESI
$9.51B
$29.6M 0.03%
+1,163,766
New +$30.2M
LEA icon
327
Lear
LEA
$8.16B
$29.6M 0.03%
254,904
-18,316
-7% -$1.96M
SHOO icon
328
Steven Madden
SHOO
$3.46B
$29.3M 0.03%
694,633
-297,008
-30% -$11.5M
ROP icon
329
Roper Technologies
ROP
$39.3B
$29.2M 0.03%
+65,594
New +$30.4M
FR icon
330
First Industrial Realty Trust
FR
$8.4B
$29.1M 0.03%
505,988
+102,439
+25% +$5.72M
PPLI
331
People Inc
PPLI
$3.01B
$29.1M 0.03%
+744,569
New +$26.1M
OTIS icon
332
Otis Worldwide
OTIS
$27.8B
$28.7M 0.03%
328,445
+302,898
+1,186% +$27.1M
CPRX
333
DELISTED
Catalyst Pharmaceutical
CPRX
$28.5M 0.03%
1,231,372
-59,687
-5% -$1.33M
WKC icon
334
World Kinect Corp
WKC
$1.9B
$28.5M 0.03%
1,170,641
-397,811
-25% -$9.81M
HOMB icon
335
Home BancShares
HOMB
$6.27B
$28.3M 0.03%
1,017,895
+229,837
+29% +$6.37M
EPRT icon
336
Essential Properties Realty Trust
EPRT
$6.71B
$27.6M 0.03%
+929,655
New +$28.3M
RRX icon
337
Regal Rexnord
RRX
$11.4B
$27.6M 0.03%
200,214
+47,561
+31% +$6.77M
GFF icon
338
Griffon
GFF
$4.8B
$27.6M 0.03%
363,381
-188,373
-34% -$14M
NBN icon
339
Northeast Bank
NBN
$1.16B
$26.9M 0.03%
256,730
-14,981
-6% -$1.4M
STRL icon
340
Sterling Infrastructure
STRL
$16.9B
$26.6M 0.03%
88,478
-10,693
-11% -$3.68M
CRUS icon
341
Cirrus Logic
CRUS
$6.08B
$26.5M 0.03%
222,247
-16,027
-7% -$1.97M
HRMY icon
342
Harmony Biosciences
HRMY
$2.24B
$26.4M 0.03%
708,943
-45,009
-6% -$1.48M
MYRG icon
343
MYR Group
MYRG
$5.1B
$26.2M 0.03%
119,986
-51,637
-30% -$11.2M
PLAB icon
344
Photronics
PLAB
$1.97B
$26.1M 0.03%
809,364
-28,078
-3% -$724K
HLLY icon
345
Holley
HLLY
$362M
$26.1M 0.03%
6,328,724
-1,323,821
-17% -$4.77M
KFY icon
346
Korn Ferry
KFY
$4.36B
$26.1M 0.03%
+393,859
New +$26.5M
BDC icon
347
Belden
BDC
$5.36B
$25.9M 0.03%
221,434
-11,947
-5% -$1.39M
HAE icon
348
Haemonetics
HAE
$4.11B
$25.8M 0.03%
322,667
-248,224
-43% -$16.7M
QRVO icon
349
Qorvo
QRVO
$8.68B
$25.5M 0.03%
304,024
-26,139
-8% -$2.31M
VC icon
350
Visteon
VC
$2.86B
$25.3M 0.03%
+264,698
New +$28M

Similar funds

Boston Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Boston Partners held 822 positions worth $96.6B, down 0.83% from $97.4B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Boston Partners's Q4 2025 filing shows 68 new, 222 increased, 455 reduced and 69 closed positions. Its largest new stake was Meta Platforms (Facebook): 1,113,139 shares worth $733M. The largest sale was Alphabet (Google) Class A, an estimated $837M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.

  • Boston Partners's largest Q4 2025 buy was Meta Platforms (Facebook): 1,113,139 shares worth $733M.
  • Boston Partners added most to Cigna in Q4 2025, an estimated $348M increase.
  • Boston Partners's biggest Q4 2025 reduction was Alphabet (Google) Class A, cutting an estimated $837M.
  • Boston Partners fully exited Harley-Davidson in Q4 2025, selling an estimated $112M.
  • Boston Partners's ten largest holdings make up 13% of its $96.6B portfolio in Q4 2025.
  • Boston Partners opened 68 new positions and closed 69 in Q4 2025.
  • Boston Partners's portfolio value fell 0.83% quarter-over-quarter to $96.6B.

Based on Boston Partners's 13F filing for Q4 2025, filed 13 Feb 2026.